May 19, 2023
CureVac SE, et al. v. BioNTech SE, et al.
Case Number:
2:23-cv-00222
Court:
Nature of Suit:
Judge:
Firms
- Desmarais LLP
- Duane Morris
- Groombridge Wu
- Kaleo Legal
- Kaufman & Canoles
- Marshall Gerstein
- McCarter & English
- McGuireWoods
- MoloLamken
- Paul Hastings
- Saul Ewing
- Spotts Fain
- White & Case
- Willkie Farr
- Winston & Strawn
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 08, 2025
GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal
British pharmaceutical company GlaxoSmithKline said Friday it stands to make up to $500 million from settlements between German biotech companies CureVac and BioNTech after their legal disputes were squashed by a merger.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login